AU7868300A - Prostate cancer marker proteins - Google Patents

Prostate cancer marker proteins

Info

Publication number
AU7868300A
AU7868300A AU78683/00A AU7868300A AU7868300A AU 7868300 A AU7868300 A AU 7868300A AU 78683/00 A AU78683/00 A AU 78683/00A AU 7868300 A AU7868300 A AU 7868300A AU 7868300 A AU7868300 A AU 7868300A
Authority
AU
Australia
Prior art keywords
prostate cancer
cancer marker
marker proteins
patients
subjects
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU78683/00A
Other languages
English (en)
Inventor
George L. Wright Jr.
Christine Yip
Tai-Tung Yip
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eastern Virginia Medical School
Aspira Womens Health Inc
Original Assignee
Eastern Virginia Medical School
Ciphergen Biosystems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22568045&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU7868300(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eastern Virginia Medical School, Ciphergen Biosystems Inc filed Critical Eastern Virginia Medical School
Publication of AU7868300A publication Critical patent/AU7868300A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU78683/00A 1999-10-07 2000-10-06 Prostate cancer marker proteins Abandoned AU7868300A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15842299P 1999-10-07 1999-10-07
US60158422 1999-10-07
PCT/US2000/027682 WO2001025791A2 (en) 1999-10-07 2000-10-06 Prostate cancer marker proteins

Publications (1)

Publication Number Publication Date
AU7868300A true AU7868300A (en) 2001-05-10

Family

ID=22568045

Family Applications (1)

Application Number Title Priority Date Filing Date
AU78683/00A Abandoned AU7868300A (en) 1999-10-07 2000-10-06 Prostate cancer marker proteins

Country Status (7)

Country Link
EP (1) EP1224466B1 (enExample)
JP (1) JP2004500553A (enExample)
AT (1) ATE350662T1 (enExample)
AU (1) AU7868300A (enExample)
CA (1) CA2386669A1 (enExample)
DE (1) DE60032784T2 (enExample)
WO (1) WO2001025791A2 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1269194B1 (en) * 2000-03-20 2007-03-07 Eastern Virginia Medical School Prostate cancer markers
AUPQ886100A0 (en) * 2000-07-19 2000-08-10 Biotron Limited Diagnostic test
GB2379737A (en) * 2001-09-05 2003-03-19 Univ Geneve Diagnostic method for spongiform encephalopathy disease
AU2003211157A1 (en) * 2002-02-21 2003-09-09 Eastern Virginia Medical School Protein biomarkers that distinguish prostate cancer from non-malignant cells
WO2004040316A2 (en) 2002-10-30 2004-05-13 Proteome Sciences Plc. Diagnostic method for transmissible spongiform encephalopathies (prion diseases)
JP4200503B2 (ja) 2002-12-26 2008-12-24 日東紡績株式会社 免疫測定法およびそれに用いるキット
US20070117164A1 (en) 2003-04-08 2007-05-24 Raskov Hans H Method for detection of colorectal cancer in human samples
US7425700B2 (en) 2003-05-22 2008-09-16 Stults John T Systems and methods for discovery and analysis of markers
JP4568551B2 (ja) * 2004-07-28 2010-10-27 一晃 掛樋 糖たん白質糖鎖の分析方法及び非標識糖鎖の製造方法
EP1866648A2 (de) * 2005-04-07 2007-12-19 mosaiques diagnostics and therapeutics AG Polypeptidmarker zur diagnose von prostatakrebs
US8409794B2 (en) * 2006-03-24 2013-04-02 Phenomenome Discoveries Inc. Biomarkers useful for diagnosing prostate cancer, and methods thereof
GB0617429D0 (en) 2006-09-05 2006-10-18 Electrophoretics Ltd Markers of renal transplant rejection and renal damage
EP2012127A3 (en) * 2007-07-03 2009-03-11 Koninklijke Philips Electronics N.V. Diagnostic markers for detecting prostate cancer
US20140134658A1 (en) * 2010-05-21 2014-05-15 Notrhwestern University, An Illinois Not For Profit Corporation Psa enzymatic activity: a new biomarker for assessing prostate cancer aggressiveness
JP2013528379A (ja) * 2010-05-21 2013-07-11 オームクス コーポレーション Ｐｓａ酵素活性アッセイによる癌の検出
CA2835806A1 (en) 2011-05-13 2012-11-22 King's College London Methods and compositions relating to platelet sensitivity
EP3047274A2 (en) * 2013-09-20 2016-07-27 Ohmx Corporation Psa enzymatic activity: a new biomarker for assessing prostate cancer aggressiveness
JP7441303B2 (ja) 2019-08-05 2024-02-29 シアー， インコーポレイテッド サンプル調製、データ生成、タンパク質コロナ分析のためのシステムおよび方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5866679A (en) * 1994-06-28 1999-02-02 Merck & Co., Inc. Peptides
US6143864A (en) * 1994-06-28 2000-11-07 Merck & Co., Inc. Peptides
US5807978A (en) * 1995-06-07 1998-09-15 Kokolus; William J. Immunogenic peptides of prostate specific antigen
JP2001518085A (ja) * 1997-03-11 2001-10-09 スローン ケタリング インスティテュート フォー キャンサー リサーチ 前立腺特異的抗原基質
US6207370B1 (en) * 1997-09-02 2001-03-27 Sequenom, Inc. Diagnostics based on mass spectrometric detection of translated target polypeptides
US6300088B1 (en) * 1997-11-24 2001-10-09 Duke University Method of detecting prostate specific antigen
WO1999037811A1 (en) * 1998-01-21 1999-07-29 Urocor, Inc. Biomarkers and targets for diagnosis, prognosis and management of prostate disease
WO1999061471A2 (en) * 1998-05-29 1999-12-02 Incyte Pharmaceuticals, Inc. Human transmembrane proteins

Also Published As

Publication number Publication date
CA2386669A1 (en) 2001-04-12
JP2004500553A (ja) 2004-01-08
DE60032784D1 (de) 2007-02-15
WO2001025791A2 (en) 2001-04-12
DE60032784T2 (de) 2007-11-08
EP1224466B1 (en) 2007-01-03
ATE350662T1 (de) 2007-01-15
EP1224466A2 (en) 2002-07-24
WO2001025791A3 (en) 2001-12-27

Similar Documents

Publication Publication Date Title
AU7868300A (en) Prostate cancer marker proteins
WO2002046477A3 (en) Endogenous retroviruses up-regulated in prostate cancer
ATE194660T1 (de) Veraendertes gen bei menschlichem colorektalem- krebs
ATE238553T1 (de) Krebsbehandlung
DK0961780T3 (da) Proteinmarkörer for lungecancer og anvendelse deraf
WO2004050026A3 (en) Compositions and methods for treating prostate cancer
WO2001072962A3 (en) Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
PT1157041E (pt) Anticorpos para terapia e diagnostico de cancro
AU2001253079A1 (en) Methods, compositions and kits for the detection and monitoring of breast cancer
AU2003205077A1 (en) Imaging agents and methods of imaging naaladase of psma
AU9779498A (en) Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor
MX9708401A (es) Genes reguladores de la cromatina.
AU2002365365A1 (en) Metal complex compounds
WO2001062784A3 (en) Use of breast cancer associated membrane proteins (bcmp) for treatment, prophylaxis and diagnosis of breast cancer
WO2001042792A3 (en) Diagnosis of cervical cancer using marker proteins
AU2596901A (en) Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
WO2002023200A3 (en) Human breast cancer biomarkers
AU2001233912A1 (en) Diagnosis of breast cancer using bcmp-81 as marker
WO2007020522A3 (en) Protein markers for diagnosing of colorectal cancer and use of said markers as drug targets for the treatment of said cancer type
ATE409226T1 (de) Polymorphe marker von prostatakarzinom tumorantigen-1 (pcta-1)
BR0012301A (pt) Inibidores de crescimento de células epiteliais
WO2001096599A3 (en) Methods for quantitative determination of b-fibronectin in biological fluids and tissues
AU2001255734A1 (en) Sigma-2 receptors as biomarkers of tumor cell proliferation
WO2003020294A8 (de) Markierung der aromatase
WO2003043566A3 (en) Hip1 cancer markers

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase